Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Lekamwasam, S; Adachi, JD; Agnusdei, D; Bilezikian, J; Boonen, S; Borgström, F; Cooper, C; Perez, AD; Eastell, R; Hofbauer, LC; Kanis, JA; Langdahl, BL; Lesnyak, O; Lorenc, R; McCloskey, E; Messina, OD; Napoli, N; Obermayer-Pietsch, B; Ralston, SH; Sambrook, PN; Silverman, S; Sosa, M; Stepan, J; Suppan, G; Wahl, DA; Compston, JE; Joint IOF–ECTS GIO Guidelines Working Group.
An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
Arch Osteoporos. 2012; 7(1-2):25-30
Doi: 10.1007/s11657-012-0070-7
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Obermayer-Pietsch Barbara
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
- Find related publications in this database (using NLM MeSH Indexing)
- Antirheumatic Agents - therapeutic use
- Glucocorticoids - adverse effects
- Humans -
- Osteoporosis - chemically induced
- Rheumatic Diseases - drug therapy